ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pregnancy"

  • Abstract Number: 0479 • ACR Convergence 2023

    Exploring Reproductive Experiences with Women Enrolled in the Vasculitis Pregnancy Registry

    Catherine Sims1, Christine Yeung2, Heather Tam3, Joyce Kullman4, Amanda Eudy5, Renee Borchin6, Cristina Burroughs6, Megan Clowse7 and Peter Merkel2, 1Duke University School of Medicine, Durham, NC, 2University of Pennsylvania, Philadelphia, PA, 3Vasculitis Patient Powered Research Network, Stanford, CA, 4Vasculitis Foundation, Kansas City, MO, 5Duke University, Raleigh, NC, 6University of South Florida, Tampa, FL, 7Duke University, Chapel Hill, NC

    Background/Purpose: There are limited data on the reproductive health and experiences of women with vasculitis. This study engaged women with vasculitis to understand their perspectives…
  • Abstract Number: 1360 • ACR Convergence 2023

    Factors Associated with Medication-related Concerns in Women with Inflammatory Rheumatic Diseases – an Analysis of a Nationwide Pregnancy Cohort

    Yvette Meissner1, Bernhard Eickhoff1, Cornelia Glaser2, Joerg Henes3, Jutta Richter4, Susanna Spaethling-Mestekemper5, Christof Specker6, Rebecca Fischer-Betz4 and Anja Strangfeld1, 1German Rheumatism Research Center, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology University Medical Center Freiburg, Freiburg, Germany, 3University Hospital Tuebingen, Tuebingen, Germany, 4Clinic for Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Düsseldorf, Germany, 5Rheumapraxis Muenchen, Muenchen, Germany, 6Department of Rheumatology and Clinical Immunology, Kliniken Essen-Mitte, Essen, Germany

    Background/Purpose: Pregnancies in women with chronic diseases are often accompanied by concerns about potential complications [1]. This analysis explored medication-related concerns among women with inflammatory…
  • Abstract Number: 0110 • ACR Convergence 2023

    Neutrophil Extracellular Traps as Mediators of Antiphospholipid Antibody-Induced Trophoblast Dysfunction and Fetal Loss

    Christine Rysenga, Srilakshmi Yalavarthi, Wenying Liang, Claire Hoy, Cyrus Sarosh, Richard Lieberman, Yu Zuo and Jason Knight, University of Michigan, Ann Arbor, MI

    Background/Purpose: Antiphospholipid antibodies (aPL) induce obstetric complications associated with placental insufficiency by promoting trophoblast dysfunction and inflammation at the maternal-fetal interface. Neutrophils have been found…
  • Abstract Number: 0586 • ACR Convergence 2023

    Therapeutic Drug Monitoring of Azathioprine and Tacrolimus in SLE Pregnancies: Preliminary Results from the LEGACY Cohort

    Reem Farhat1, Arielle Mendel2, Isabelle Malhamé3, Joo Young (Esther) Lee4, Luisa Ciofani5, Sasha Bernatsky6 and Evelyne Vinet2, 1McGill University, Montréal, QC, Canada, 2McGill University Health Centre, Montréal, QC, Canada, 3McGill University Health Centre, Montreal, QC, Canada, 4McGill University, Montreal, QC, Canada, 5McGill University Health Center, Montreal, QC, Canada, 6Research Institute of the McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Pregnant SLE women still face an unacceptably high risk of maternal and fetal morbidity, particularly when their disease is active. How to personalize SLE…
  • Abstract Number: 1361 • ACR Convergence 2023

    Effect of Zen/Doria Remission and Glucocorticoid Dosage on the Pregnancy Outcome of SLE: Retrospective Study in Two Japanese Tertiary Referral Centers

    Takehiro Nakai1, Nanase Honda2, Sho Fukui3, Ayako Kitada1, Naoto Yokogawa4 and Masato Okada1, 1St. Luke's International Hospital, Tokyo, Japan, 2Tokyo Metropolitan Tama Medical Center, Fuchu-shi, Japan, 3Brigham and Women's Hospital, Boston, MA, 4Tokyo Metropolitan Tama Medical Center, Taito City, Tokyo, Japan

    Background/Purpose: Achieving remission is one of the treatment targets in the lupus care and it is also important in preventing the prevalence of adverse pregnancy…
  • Abstract Number: L13 • ACR Convergence 2022

    Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block

    Stephanie Benjamin1, Lisa Vi2, Diptendu Chatterjee1, Edgar Jaeggi1, Marie Wahren-Herlenius3, Amelia Ruffatti4, Linda Hiraki5, Michelle Lohbihler2, Lusia Sepiashvili1, Carl Laskin6, Meena Fatah1, Daniela Dominguez5, Lawrence Ng5, Anthony Gramolini2, Vincent Christoffels7, Stephanie Protze2 and Robert Hamilton8, 1Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 4Universitå di Padova, Padova, Italy, 5The Hospital for Sick Children, Toronto, ON, Canada, 6Mt. Sinai Hospital/University of Toronto, Toronto, ON, Canada, 7Amsterdam UMC, Amsterdam, Zuid-Holland, Netherlands, 8Hospital for Sick Children, Markham, ON, Canada

    Background/Purpose: Autoimmune congenital heart block (CHB+) affects the fetus of mothers with anti-Ro antibodies. Anti-Ro (Ro+) antibodies (Abs) are usually present in maternal sera when…
  • Abstract Number: 0950 • ACR Convergence 2022

    Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status: Data from the COVID-19 Global Rheumatology Alliance Registry

    Sinead Maguire1, Samar Al emadi2, Paul Alba3, Mathia C Aguiar4, Talal Al Lawati5, Gelsomina Alle6, Bonnie Bermas7, Suleman Bhana8, Branimir Anic9, Inita Bulina10, Megan Clowse11, Adriana Karina Cogo12, Iris Colunga13, Claire Cook14, KAREN JOYCE CORTEZ15, Kathryn Dao16, Milena Gianfrancesco17, Monique Gore-Massy18, Laure Gossec19, Rebecca Grainger20, Jonathan Hausmann21, Tiffany YT Hsu22, Kimme Hyrich23, Carolina Isnardi24, Yumeko Kawano22, Rachael Kilding25, Daria A Kusevich26, Saskia Lawson-Tovey27, Jean Liew28, Eoghan McCarthy29, Anna Montgomery30, Sebastian Moyano3, Noreen Nasir31, IVAN PADJEN32, Charalampos Papagoras33, Naomi Patel34, MARIANA PERA35, Cecilia Pisoni36, Guillermo Pons-Estel37, Antonio Lorenzo Quiambao38, Rosana Quintana39, Eric Ruderman40, Sebastian Sattui41, Veronica Savio42, Savino Sciascia43, Marieta Sencarova44, Rosa Serrano-Morales45, Faizah Siddique46, Emily Sirotich47, Jeffrey Sparks48, Anja Strangfeld49, Paul Sufka50, Helen Tanner51, Yohana Tissera52, Zachary Wallace14, Marina Werner53, Leanna Wise54, Angus Worthing55, JoAnn Zell56, Julija Zepa10, Pedro Machado57, Jinoos Yazdany17, Philip Robinson51 and Richard Conway1,1St James' Hospital, Dublin, Ireland, 2Hamad Medical Corporation, Doha, Qatar, 3Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Hospital General Agustin O`Horan, Merida, Mexico, 5Sultan Qaboos University Hospital, Muscat, Oman, 6Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 7UT Southwestern, Dallas, TX, 8Crystal Run Healthcare, Middletown, NY, 9Clinical Hospital Centre Zagreb, School of Medicine, University of Zagreb, Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Zagreb, Croatia, 10Center of Rheumatology, Paul Stradins Clinical University hospital, Riga, Latvia, 11Duke University, Durham, NC, 12Hospital Interzonal Luis Guemes, Haedo and Hospital San Juan de Dios, Castelar, Buenos Aires, Argentina, 13Hospital Universitario UANL, Monterrey, Mexico, 14Massachusetts General Hospital, Boston, MA, 15Baguio General Hospital Medical Center, Baguio, Philippines, 16UT Southwestern Medical Center, Dallas, TX, 17University of California San Francisco, San Francisco, CA, 18Covid-19 GRA, West Orange, NJ, 19Sorbonne Université, Paris, France, 20University of Otago, Wellington, New Zealand, 21Division of Immunology, Boston Children's Hospital, Boston, MA, 22Brigham and Women's Hospital, Boston, MA, 23The University of Manchester, Manchester, United Kingdom, 24SAR-COVID Coordinator, Research Unit Argentine Society of Rheumatology, Buenos Aires, Argentina, 25Sheffield teaching hospitals trust, Sheffield, United Kingdom, 26VA Nasonova Research Institute of Rheumatology, Moscow and Anikina Clinic, Vidnoe, Russia, 27Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, the University of Manchester, Manchester, UK AND National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, 28Boston University, Boston, MA, 29Beaumont Hospital, Dublin, Ireland, 30University of California, San Francisco, USA; San Francisco VA Medical Center, San Francisco, USA, San Francisco, CA, 31Aga Khan University Hospital, Karachi Pakistan, Karachi, Pakistan, 32University Hospital Center Zagreb, Zagreb, Croatia, 33First Department of Internal Medicine and Laboratory of Molecular Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece, 34Massachusetts General Hospital, Sale Creek, TN, 35Hospital Ángel C Padilla, San Miguel de Tucumán, Tucuman, Argentina, 36CEMIC- Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina, 37Argentine Society of Rheumatology, Buenos Aires, Argentina, 38East Avenue Medical Center, Quezon City, Philippines, 39Centro Regional de Enfermedades Autoinmunes y Reumáticas. Grupo Oroño (GO CREAR) and Research Unit Argentine Society of Rheumatology, Buenos Aires, Argentina, 40Northwestern University Feinberg School of Medicine, Chicago, IL, 41University of Pittsburg, Pittsburg, Pennsylvania, USA, PIttsburgh, PA, 42Hospital Córdoba; Consultora Integral de Salud CMP, Cordoba, Argentina, 43University of Turin, Torino, Italy, 44Univerzitna nemocnica L Pasteura, Slovakia, Kosice, Slovakia, 45Sanatorio Parque. Centro de Enfermedades Autoinmunes y Reumáticas del Grupo Oroño, Rosario, Argentina, 46Loyola University Medical Center, Elmhurst, IL, 47Department of Health Research, Evidence and Impact, McMaster University, Hamilton, ON, Canada, 48Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 49Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 50HealthPartners, Eagan, MN,51University of Queensland School of Medicine, Brisbane, Queensland, Australia, 52Internal Medicine Service, Rheumatology Unit, Hospital Córdoba y Sanatorio Parque de Córdoba, Córdoba, Argentina, 53Hospital Nacional de Clínicas, Córdoba, Argentina, 54LAC+USC/Keck Medicine of USC, Pasadena, CA, 55Arthritis & Rheumatism Associates, PC, Washington, DC, 56University of Colorado Anschutz Medical Campus, Aurora, CO, 57Centre for Rheumatology & Department of Neuromuscular Diseases, University College London and National Institute for Health Research (NIHR), University College London Hospitals NHS Foundation Trust, and Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, United Kingdom

    Background/Purpose: To describe obstetric outcomes based on COVID-19 vaccination status in women with rheumatic and musculoskeletal diseases (RMDs) who developed COVID-19 during pregnancy.Methods: We extracted…
  • Abstract Number: 0969 • ACR Convergence 2022

    Use of Gonadotropin-releasing Hormone Agonists for Ovarian Preservation in Patients Receiving Cyclophosphamide for Systemic Lupus Erythematosus: A Meta-analysis

    Komal Ejaz1, Dania Abid2, Paul Juneau3, Jun Chu4 and Sarfaraz Hasni5, 1The Wright Center for Graduate Medical Education, Scranton, PA, 2Idaho College of Osteopathic Medicine, Meridian, ID, 3National Institutes of Health Library, Bethesda, MD, 4National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 5National Institutes of Health, Bethesda, MD

    Background/Purpose: Cyclophosphamide (CYC) has known cytotoxic effects on ovarian reserve and has been linked to premature ovarian failure in systemic lupus erythematosus (SLE). The concurrent…
  • Abstract Number: 0952 • ACR Convergence 2022

    Pregnancy Course and Outcomes of Patients with Polymyositis and Dermatomyositis (PM/DM) in Our Institution

    Rina Mino1, Hiromi Shimada2, Risa Wakiya2, shusaku nakashima3, Mikiya Kato2, taichi miyagi4, Yusuke Ushio5, Kanako Chujo6, Tomohiro Kameda2 and Hiroaki Dobashi7, 1Kagawa University, Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Miki-cho, Kita-gun, Japan, 2Kagawa University, Kagawa, Japan, 3Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa, Japan, 4Kagawa University, Kidagun, Japan, 5Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki, Kita District, Kagawa, Japan, 6Kagawa University, Miki, Kita District, Kagawa, Japan, 7Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa, Kagawa, Japan

    Background/Purpose: The purpose of this study is to determine the association between changes in disease activity during pregnancy and pregnancy outcome by analyzing a case…
  • Abstract Number: 1335 • ACR Convergence 2022

    Artificial Intelligence–enabled Sentiment Analysis of Public Attitude Toward Pregnancy in Lupus Social Media Group

    Gopisree Peringeth1 and Milena Vukelic2, 1Jacobi Medical Center/Albert Einstein College of Medicine, New York, NY, 2Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Lupus commonly affects women of reproductive age whose pregnancies are associated with higher rates of complications and fetal loss. There is a knowledge gap…
  • Abstract Number: 0953 • ACR Convergence 2022

    Increased Risk of Preterm Delivery Phenotypes and Hypertensive Disorders of Pregnancy in First Deliveries of Patients with Systemic Vasculitis

    Audra Horomanski1, Gary Shaw2, Jonathan Mayo3 and Julia Simard4, 1Stanford University, Stanford, CA, 2Stanford University School of Medicine, Palo Alto, 3Stanford University, Stanford, 4Stanford University School of Medicine, Palo Alto, CA

    Background/Purpose: Systemic vasculitides are rare disorders characterized by vascular inflammation that can affect virtually every organ system. Recent treatment advances have increased life expectancy and…
  • Abstract Number: 1465 • ACR Convergence 2022

    Clinical Profiling and Antiphospholipid Antibody (aPL) Associations in Indian Systemic Lupus Erythematosus (SLE) Cohort

    Vineeta Shobha1, Liza Rajasekhar2, Sandra Manuel1, Chengappa Kavadichanda3, Ashish J Mathew4, Ranjan Gupta5, Manish Rathi6, Parasar Ghosh7, Saumya Ranjan Tripathy8, Avinash Jain9 and Amita Aggarwal10, 1St. John’s Medical College Hospital, Bangalore, India, 2Nizam's Institute of Medical Sciences, Madhapur, India, 3JIPMER, Pondicherry, Puducherry, India, 4Rigshospitalet, Copenhagen, Denmark, 5All India Institute of Medical Sciences, New Delhi, India, 6PGIMER Chandigarh, Chandigarh, India, 7Govt of West Bengal, Kolkata, India, Kolkata, West Bengal, India, 8SCB medical college, Cuttack, India, 9SMS Medical College, Lucknow, India, 10Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose: Antiphospholipid Antibody (aPL) are described in 11-40% of patients with SLE. Whether the presence of any of the aPLs or combinations thereof, can accurately…
  • Abstract Number: 0954 • ACR Convergence 2022

    What Drives the BASDAI in Pregnant Patients with Axial Spondyloarthritis? A Pooled Analysis of Four European Pregnancy Registries

    Yvette Meissner1, Nathalie Costedoat-Chalumeau2, Rebecca Fischer-Betz3, Frauke Foerger4, Anna Molto5, Marianne Wallenius6 and Anja Strangfeld1, 1Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 2Inserm DR Paris 5, Paris, France, 3Uniklinik Duesseldorf, Duesseldorf, Germany, 4Inselspital Bern, Bern, Switzerland, 5Rheumatology Department, Cochin Hospital, APHP, Paris, France, 6St. Olav University Hospital, Trondheim, Norway

    Background/Purpose: The patient reported Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) includes the six components fatigue, neck, back or hip pain, pain or swelling in…
  • Abstract Number: 1616 • ACR Convergence 2022

    Drug Use and Pregnancy Outcomes in Pregnant Women with Systemic Vasculitis: A Nation Wide Cohort Study

    Camille Mettler1, Nathanaël Beeker2, Mathis Collier2, Veronique Le Guern3, Benjamin Terrier4 and Laurent Chouchana5, 1Department of Internal Medicine, National Referral Center for Rare Systemic and Autoimmune Diseases, Cochin Hospital, Paris, France, 2Unité de Recherche clinique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France, 3Hôpital Cochin, Paris, France, 4National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 5Pharmacology department, Centre Régional de Pharmacovigilance, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France

    Background/Purpose: Women of childbearing age are rarely affected by systemic vasculitis (SV), explaining the lack of solid data regarding pregnancy in these patients. The objective…
  • Abstract Number: 0955 • ACR Convergence 2022

    Unfavorable Pregnancy Outcome Is Significantly Associated with Corticosteroid Exposure During Pregnancy in Women with RA: Analysis of the Prospective GR2 Cohort

    SABRINA HAMROUN1, Marion Couderc2, Rene-Marc Flipo3, Laure Gossec4, Christophe Richez5, Rakiba Belkhir6, Aline Frazier-Mironer7, Valerie Devauchelle8, Hubert Marotte9, Jérémie SELLAM10, elisabeth gervais11, Alban DEROUX12, Cédric Lukas13, Emmanuelle Dernis14, Emmanuel Chatelus15 and Anna Molto16, 1Rheumatology Department, University Hospital of Cochin, Paris, Paris, France, 2University Hospital, Clermont-Ferrand, France, 3CHU Lille, Boulogne-Billancourt, France, 4Sorbonne Université, Paris, France, 5Université de Bordeaux, Bordeaux, France, 6Rheumatology departement, Bicêtre, Paris-Saclay university, Le Kremlin Bicêtre, France, 7APHP Hôpital Lariboisire, Paris, France, 8Université de Bretagne Occidentale, Brest, France, 9INSERM 1059, Saint-Etienne, France, 10Sorbonne Universite, AP-HP, Saint-Antoine hospital, Paris, France, 11chu poitiers, Poitiers, France, 12CHU Grenoble, Grenoble, France, 13University Hospital Centre Montpellier, University of Montpellier, Montpellier, France, 14LE MANS general hospital, LE MANS, France, 15University Hospital of Strasbourg, Strasbourg, France, 16Rheumatology Department, Cochin Hospital, APHP, Paris, France

    Background/Purpose: Rheumatoid arthritis (RA) is one of the most common chronic inflammatory diseases and regularly affects women of childbearing age. However, there is limited knowledge…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology